# A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer

> clinical trial · VERIFIED · 2026-08-03

Status: ACTIVE_NOT_RECRUITING · Sponsor: AstraZeneca · Condition: Metastatic Breast Cancer

- Company: AstraZeneca
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT04556773

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.